research
Development of Therapeutics
for Refractory Lung Diseases
We have established high-quality differentiation methods of generating lung constituent cells derived from human iPS cells. By creating human lung organoids and recapitulating the in vivo-like cellular interactions in a dish, we have elucidated the mechanism of lung diseases, hopefully leading to drug discovery in unprecedented ways.
Regeneration of the Lung as An Organ
If a refractory lung disease progresses, the original lung structure can be irreversibly damaged and has been difficult to regenerate itself. We aim to develop therapeutic methods to regenerate lungs using iPS cells.
environment
Various facilities are available for shared use within Kyoto University and CiRA, providing a well-organized research environment.
publications
Besides the laboratory's own research projects, we are also actively engaged in joint research both within and outside Kyoto University.
member
Our laboratory staffs consist of
faculty researchers, technical assistants, and administrative staffs.
